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1 Both authors contributed equally to this study andGPR48 can mediate keratinocyte proliferation and migration. Our investigations showed that
AG1478, an inhibitor of EGFR tyrosine kinase, could block GPR48-mediated cellular processes.
AG1478 treatment of Gpr48+/+ cells also decreased phosphorylation of EGFR, ERK and STAT3. Subse-
quent screening using conditioned media immunodepleted of EGFR ligands identiﬁed HB-EGF as the
ligand responsible for phosphorylation of EGFR, ERK and STAT3. HB-EGF was reduced in Gpr48/
cell culture medium, but its addition restored the phosphorylation of EGFR, ERK, STAT3, as well as
cell proliferation. Conﬁrmation that GPR48 mediates EGFR signaling pathway through HB-EGF
was subsequently performed using an inhibitor of HB-EGF.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The signaling pathways controlling the proliferation and migra-
tion of epidermal keratinocytes serve as a model for the under-
standing of epithelial cell migration and growth responsible for
wound healing and tumorigenesis. Studies had demonstrated that
activation of the epidermal growth factor (EGF) receptor by several
ligands, such as EGF, heparin binding EGF (HB-EGF), and trans-
forming growth factor-a (TGF-a), is a central event in the regula-
tion of epithelial cell proliferation and migration [1,2]. EGFR
activation can trigger several signaling pathways including extra-
cellular signal-regulated kinase 1/2 (ERK1/2), signal transducer
and activator of transcription 3 (STAT3), and c-Jun, which are all
important for eyelid closure and keratinocyte migration [2–4].
Similarly, deﬁciencies in members of the EGFR pathway including
TGF-a, HB-EGF and EGFR using knockout mice have been shown to
be associated with the eye open at birth (EOB) phenotype [2,3].chemical Societies. Published by E
gy and Optometry, Wenzhou
ng 325003, China. Fax: +011
shared ﬁrst authorship.We have demonstrated previously that inactivation of G pro-
tein-coupled receptor 48 (GPR48) also induced the EOB phenotype
by reducing epithelial cell proliferation and migration through
EGFR signaling [5]. Gpr48 deﬁcient mice, generated using a secre-
tory trap approach to delete the majority of the Gpr48 gene or by
targeted deletion of part of exon 18, are responsible for a wide
range of developmental defects ranging from the renal system,
the ocular system, eyelids and the male reproductive tracts
[5–11]. Although GPR48 is an orphan receptor, the physiologic
functions that are being attributed to this receptor continue to
intrigue us by its diversity [12–14]. In this study, we explored
the signaling pathways that GPR48 utilizes in keratinocyte prolif-
eration and migration using Gpr48/ keratinocytes. With the help
of various chemical inhibitors, each step of the EGFR pathway was
sampled and compared with a Gpr48/ background to conﬁrm its
necessity in EGFR transactivation.
2. Materials and methods
2.1. Mice
Gpr48+/ mice were generated as previously described [11].
Heterozygous mice were intercrossed to generate homozygouslsevier B.V. All rights reserved.
4058 Z. Wang et al. / FEBS Letters 584 (2010) 4057–4062Gpr48/ mice. All studies were approved by the Wenzhou Medical
College Animal Care and Use Committee.
2.2. BrdU assay in vitro
Isolation of primary murine keratinocytes was performed
according to the protocols described previously [5]. To measure
cell proliferation, cultured primary keratinocytes were pre-treated
with AG1478 (1 lM; Calbiochem) or HB-EGF (20 ng/ml; R&D Sys-
tems) for 48 h, then incubated with BrdU (50 lg/ml; Sigma) for
5 h, ﬁxed in methanol/acetone (1:1), and subsequently incubated
with 95% formamide at 70 C for 45 minutes. Immunochemical
staining for BrdU was performed with the use of a monoclonal
antibody (DAKO, 1:100; DakoCytomation) and a mouse ABC kit
(UniTect; Calbiochem). The number of BrdU-positive cells was
counted for ten random high power microscopic ﬁelds (400X
objective).
2.3. In vitro scratch assay
To determine cell motility, primary keratinocytes grown to
80% conﬂuence were scratched using a 200-ll pipette tip, and
continued culture with AG1478 (1 lM) or HB-EGF (20 ng/ml) for
48 h. The number of migrating cells was quantiﬁed as described
previously [5].
2.4. Immunoblot and co-immunoprecipitation analysis
Gpr48+/+ and Gpr48/ cells were harvested and analyzed by
Western blotting as described previously [5]. Pretreatment of wild-
type keratinocytes with CRM197 (Sigma) was performed at differ-
ent concentrations prior to cell harvesting [15]. Protein lysates
(50 lg each) were separated by 6% (for p-Tyr, p-EGFR and total
EGFR), 10% (for p-STAT3 and total STAT3), 12% (for p-ERK1/2,
JNK, and total ERK1/2, JNK), 15% (for HB-EGF) SDS–PAGE, and
transferred to Schleicher and Schuell nitrocellulose membranes
(Whatman). After incubating with blocking buffer, the blots were
probed with antibodies for p-Tyr (PY99), p-EGFR (Tyr 1173), p-
STAT3 (Tyr 705), p-ERK(Ser 42/44), p-JNK (Thr 183/Tyr 185), total
EGFR, STAT3, ERK, JNK, HB-EGF. The blots were developed by the
supersignal chemiluminescence system (Pierce). Antibodies for to-
tal EGFR, STAT3, ERK, JNK, and p-STAT3, ERK, JNK were from Cell
Signal; antibodies for p-Tyr (PY99), p-EGFR, total HB-EGF were
from Santa Cruz Biotechnology. For co-immunoprecipitation, cell
lysates were pre-cleared by incubation with nProtein A Sepharose
4 Fast (GE healthcare) for overnight at 4 C with gentle rotation.
Beads were washed extensively with washing buffer and immune
complexes were eluted in 2X loading buffer, boiled, microcentri-
fuged and subjected to immunoblot analysis.- - + +
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B
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Fig. 1. GPR48 is required for the phosphorylation of EGFR. (A) Western blot analysis of EG
or absence of GPR48 led to lower density of p-EGFR. (B) Quantiﬁcation of band density2.5. Immunodepletion of EGFR ligands from conditioned medium
Conditioned medium (CM) was prepared as described previ-
ously [16]. One milliliter of CM was immunoprecipitated overnight
at 4 C with 10 lg of EGFR ligand antibodies (TGF-a, HB-EGF, and
EGF) or control antibodies pre-coupled to nProtein A Sepharose 4
Fast. The immunocomplexes were separated from the CM by cen-
trifugation through a 0.45 mM Ultrafree-MC ﬁlter unit (Millipore),
and the CM was tested for its ability to activate EGFR, ERK and
STAT3 of Gpr48/ primary keratinocytes. TGF-a, HB-EGF, and
EGF antibodies were from Santa Cruz Biotechnology.
2.6. Analysis of HB-EGF in conditioned medium
The CM, containing 1000 lg of protein, was immunoprecipi-
tated overnight at 4 C with 10 lg of HB-EGF antibody. The immu-
nocomplexes were separated by 15% SDS–PAGE and analyzed by
Western blotting.
2.7. Statistical analysis
All applicable data are shown as mean values ± S.E.M. The Stu-
dent’s t-test was used to determine the signiﬁcance of differences
between population means.
3. Results
3.1. GPR48 is required for EGFR phosphorylation
Western blot analysis showed that although the total EGFR
expression was unaffected in mutant keratinocytes, the activation
of EGFR was reduced in Gpr48/ keratinocytes (Fig. 1A). Introduc-
tion of AG1478 [17] also reduced EGFR phosphorylation in Gpr48+/+
keratinocytes, to a level comparable to that observed in Gpr48/
keratinocytes (Fig. 1A). The densities of the phosphorylated-EGFR
bands were 219.7 ± 36.1 and 114.3 ± 54.2 for wildtype and mutant
keratinocytes without AG1478 (Fig. 1B). The density measured
130.7 ± 40.9 and 78.0 ± 15.6 for wildtype and mutant keratinocytes
with AG1478, respectively.
3.2. EGFR phosphorylation is required for keratinocyte proliferation
and migration
A decrease in proliferation was observed in Gpr48/ keratino-
cytes compared with Gpr48+/+ cells, as shown previously [5]. After
the addition of AG1478 to cultured Gpr48+/+ keratinocytes, cell pro-
liferation decreased to levels similar to Gpr48/ keratinocytes
(Fig. 2A and B). In BrdU assays, wildtype cells without treatment
with AG1478 showed a 49.6 ± 1.2% (n = 3) rate of proliferation,-1478 - +
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Fig. 2. GPR48-induced EGFR activation is important for keratinocyte proliferation and migration. (A) Treatment with AG1478 or the absence of GPR48 inhibited the
proliferation of keratinocytes in BrdU assays. (B) Quantiﬁcation of BrdU-positive cells from (A) is shown. (C) Monolayers of keratinocytes were subjected to in vitro scratch
assays. Both Gpr48/ and treatment with AG1478 inhibited the migration of keratinocytes. (D) The quantity of migrating cells from (C) was determined by counting the
number of the cells that migrated across the gap.
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Fig. 3. GPR48 increases ERK and STAT3 phosphorylation. (A) Western blot analysis
of ERK, STAT3, JNK and phorphorylated ERK, STAT3, and JNK in wildtype and
Gpr48/ keratinocytes. (B) Following treatment with AG1478, Western blot
analysis of wildtype cell lysates showed decreased phosphorylation of ERK and
STAT3 in comparison to control, but similar to the amount produced by Gpr48/
keratinocytes.
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treatment (30.2 ± 0.2%), mutants without (38.9 ± 0.7%) and with
(32.1 ± 1.8%) treatment.
As previously shown, Gpr48/ keratinocytes had decreased
migration in in vitro scratch assays [5]. The addition of AG1478 re-
sulted in signiﬁcantly fewer Gpr48+/+ cells migrating into the gap
when compared to non-treated Gpr48+/+ keratinocytes, but compa-
rable to Gpr48/ keratinocytes (Fig. 2C and D). Total number of
cells that migrated into the gap in wildtype without AG1478 treat-
ment was 53.6 ± 11.1 (n = 3), which was signiﬁcantly different
from wildtype with treatment (30.3 ± 10.5) or mutants without
(37.5 ± 6.4) or with (18.9 ± 6.4) treatment.
3.3. GPR48 is required for the activation of ERK and STAT3 in the EGFR
signaling pathway
Western blot analysis showed that although total ERK and
STAT3 expression was unaffected in the mutant keratinocytes,
the activation of ERK and STAT3 by phosphorylation was reduced
in Gpr48/ keratinocytes compared with Gpr48+/+ keratinocytes
(Fig. 3A). Unexpectedly, Gpr48/ keratinocytes expressed similar
levels of both total and phosphorylated JNK compared with wild-
type keratinocytes (Fig. 3A). As shown in Fig. 3B, the treatment
of Gpr48+/+ keratinocytes with AG1478 for 20 minutes resulted in
diminished levels of phosphorylated ERK and STAT3, down to lev-
els observed with Gpr48/ cells.
3.4. GPR48-mediated EGFR transactivation occurs through HB-EGF
In EGFR transactivation, external stimuli activate metallopro-
teinases of the zinc-dependent disintegrin and metalloproteinasefamily, resulting in the release of precursor forms of the EGFR li-
gands such as EGF, HB-EGF and TGF-a [18–21]. Gpr48+/+ condi-
tioned medium immunodepleted of EGF or TGF-a did not affect
EGFR, ERK and STAT3 phosphorylation of Gpr48/ keratinocytes
(Fig. 4A). In contrast, Gpr48+/+ CM immunodepleted with HB-EGF
antibody harbored a reduced ability to stimulate EGFR, ERK and
STAT3 phosphorylation. Conditioned medium obtained from con-
ﬂuent cultures of Gpr48+/+ and Gpr48/ primary keratinocytes
showed that Gpr48/ cells expressed much lower levels of soluble
HB-EGF when compared to Gpr48+/+ cells (Fig. 4B). Phosphorylation
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Fig. 4. HB-EGF is required for the GPR48-induced EGFR phosphorylation. (A) Depletion of HB-EGF in CM inhibited the phosphorylation of EGFR and the EGFR downstream
target molecules. CM of Gpr48+/+ keratinocytes immunodepleted of HB-EGF showed a reduced ability to stimulate phosphorylation of EGFR, ERK and STAT3 of Gpr48/
keratinocytes, similar to CM of Gpr48/ keratinocytes. (B) HB-EGF was decreased in the CM of Gpr48/ primary keratinocytes. (C) The treatment of Gpr48/ primary
keratinocytes with HB-EGF resulted in a higher level of phosphorylated-EGFR (p-EGFR) in comparison to those without treatment. (D) Wildtype primary keratinocytes were
pre-treated with 10 or 15 lg/ml of CRM197, an inhibitor of HB-EGF, for 30 minutes, the cells were harvested and subjected to Western blot analysis against phosphorylated
EGFR, ERK and STAT3.
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rescued to a level similar to that of Gpr48+/+ keratinocytes, after
the addition of HB-EGF (Fig. 4C). Pretreatment of Gpr48+/+ keratino-
cytes with CRM197, a HB-EGF inhibitor, decreased GPR48-induced
EGFR, ERK and STAT3 activation (Fig. 4D).
3.5. HB-EGF is important for GPR48-mediated cell proliferation
As shown in Fig. 5A, the addition of HB-EGF to cultured Gpr48/
 keratinocytes allowed cell proliferation to increase to levels sim-A
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Fig. 5. HB-EGF can rescue the proliferation of Gpr48/ keratinocytes. (A) HB-EGF can re
Cell migration, though improved, was not signiﬁcantly increased in Gpr48/ primary kilar to those of Gpr48+/+ keratinocytes. The addition of HB-EGF to
cultured Gpr48/ keratinocytes was only partially effective (not
statistically signiﬁcant) in restoring the ability of cells to migrate
in the scratch assay (Fig. 5B).
4. Discussion
Transactivation of EGFR by G protein-coupled receptors
(GPCR) illustrates the complexities of inter-receptor communica-
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ligands act synergistically leading to autocrine/paracrine loops
that contribute to cell proliferation and migration [18]. Aberrant
regulation of GPCRs has been implicated in the development of
tumors in this microenvironment [21,22].
We have previously demonstrated that GPR48 regulates epithe-
lial cell proliferation and migration by activating EGFR during eye-
lid development [5]. Initial investigations using inhibitors of EGFR
activation by AG1478 demonstrated an essential role of EGFR sig-
naling in epithelial cell proliferation and migration. Addition of
AG1478 led to decreased levels of ERK and STAT3 with concurrent
anti-proliferative and anti-migratory effects on Gpr48+/+ keratino-
cytes (Figs. 2 and 3). Our results suggest that ERK and STAT3 play
an essential role in transducing a signal required for proliferation
and migration of keratinocytes.
The activation of EGFR is mediated, at least in part, by HB-EGF,
which is cleaved from its membrane-anchored form (pro-HB-EGF)
by speciﬁc metalloproteinases. Release of transmembrane HB-EGF
serves as a strong stimulus in the transactivation of EGFR by G-pro-
tein-coupled receptors [19], which ultimately leads to increased
cell proliferation and migration. In this study, we showed that
HB-EGF is the primary ligand responsible for GPR48-mediated
EGFR signaling (Fig. 4). Western blot analysis conﬁrmed the role
of HB-EGF and discovered that the expression level of phosphory-
lated EGFR, ERK and STAT3 were all dramatically decreased in
Gpr48/ keratinocytes. Functionally, HB-EGF was able to rescue
the proliferation of Gpr48/ keratinocytes to a level similar to
Gpr48+/+ keratinocytes (Fig. 5). Blockade of HB-EGF by CRM197
inhibited the GPR48-induced activation of EGFR, ERK and STAT3
in wildtype epidermal keratinocytes.
Although the soluble form of HB-EGF is a potent mitogen and
chemoattractant for many cell types, the catalyst in the proteolytic
processing of HB-EGF remains elusive. Physiologic roles as a result
of proteolytic release of HB-EGF include keratinocyte migration in
cutaneous wound healing [4], cell migration in eyelid development
[2], cornea epithelial cell migration [23], cardiac hypertrophy [20]
and lung epithelial cell movements in response to gram-positive
bacterial challenge [24]. Members of the ADAM family of protein-
ases such as ADAM9, ADAM10, ADAM12, and ADAM17 are impli-
cated in the endoproteolytic release of HB-EGF [20,25–27]. Our
own studies have also shown that the expression level of matrix
metalloproteinase 7 (MMP-7) is signiﬁcantly higher in Gpr48+/+
keratinocytes than in Gpr48/ cells (data not shown).
Overall, our data indicated that GPR48 is one of the constituents
responsible for the EGFR signaling pathway with its effects directly
linked to its ligand, HB-EGF. The ability of GPR48 to initiate the cas-
cade of events leading to EGFR transactivation is a highly intercon-
nected and coordinated process. Despite the current expanding
understanding in this arena, it remains a fertile ground for investi-
gation into the molecular mechanisms behind cellular proliferation
and tumorigenesis.
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